Title: Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysis.
Journal: Chemical research in toxicology 20110919
Title: Oral absorption of clarithromycin is nearly abolished by chronic comedication of rifampicin in foals.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110901
Title: A validated liquid chromatography-tandem mass spectrometry method for the quantitative determination of 4β-hydroxycholesterol in human plasma.
Journal: Journal of pharmaceutical and biomedical analysis 20110715
Title: Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol.
Journal: European journal of clinical pharmacology 20110701
Title: Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians.
Journal: The pharmacogenomics journal 20110401
Title: 4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans.
Journal: British journal of clinical pharmacology 20110201
Title: Does the long plasma half-life of 4beta-hydroxycholesterol impact its utility as a cytochrome P450 3A (CYP3A) metric?
Journal: Journal of clinical pharmacology 20101101
Title: 4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man.
Journal: International journal of clinical pharmacology and therapeutics 20091201
Title: Human exposure to triclosan via toothpaste does not change CYP3A4 activity or plasma concentrations of thyroid hormones.
Journal: Basic & clinical pharmacology & toxicology 20091101
Title: Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric?
Journal: Clinical pharmacology and therapeutics 20090801
Title: Efficient chemoenzymatic synthesis, cytotoxic evaluation, and SAR of epoxysterols.
Journal: Journal of medicinal chemistry 20090709
Title: Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS.
Journal: Journal of lipid research 20090201
Title: 4beta-hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin.
Journal: British journal of clinical pharmacology 20090101
Title: Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol.
Journal: Clinical pharmacology and therapeutics 20081101
Title: CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels.
Journal: European journal of clinical pharmacology 20080801
Title: Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy.
Journal: British journal of clinical pharmacology 20080501
Title: 4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians.
Journal: Pharmacogenetics and genomics 20080301
Title: Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin.
Journal: Pharmacogenetics and genomics 20060801
Title: Electron ionization mass spectral fragmentation of cholestane-3beta,4alpha,5alpha-triol and cholestane-3beta,5alpha,6alpha/beta-triol bis- and tris-trimethylsilyl derivatives.
Journal: Rapid communications in mass spectrometry : RCM 20050101
Title: Analysis of cholesterol oxidation products in biological samples.
Journal: Journal of AOAC International 20040101
Title: Metabolism of 4 beta -hydroxycholesterol in humans.
Journal: The Journal of biological chemistry 20020830
Title: Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4.
Journal: The Journal of biological chemistry 20011019
